A I Hartstein
- Infectious Diseases top 5%
- Epidemiology top 10%
- Clinical Biochemistry top 2%
- Pharmacology top 10%
- Molecular Medicine top 5%
- Co-authors
- Virginia H. MorthlandPloenchan ChetchotisakdRichard TuckerPamela WilliamsMaury E. MulliganL H HansonR Y KwokEduardo Arathoon
- Topics
- Antimicrobial Resistance in Staphylococcus (5 papers)Bacterial Identification and Susceptibility Testing (4 papers)Antibiotic Resistance in Bacteria (3 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- United States
In The Last Decade
A I Hartstein
14 papers receiving 660 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 428
- Epidemiology 285
- Clinical Biochemistry 188
- Pharmacology 140
- Molecular Medicine 118
Countries citing papers authored by A I Hartstein
This map shows the geographic impact of A I Hartstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A I Hartstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A I Hartstein more than expected).
Fields of papers citing papers by A I Hartstein
This network shows the impact of papers produced by A I Hartstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A I Hartstein. The network helps show where A I Hartstein may publish in the future.
Co-authorship network of co-authors of A I Hartstein
This figure shows the co-authorship network connecting the top 25 collaborators of A I Hartstein. A scholar is included among the top collaborators of A I Hartstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A I Hartstein. A I Hartstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. | 77 |
| 3 | 25 | |
| 4 | 72 | |
| 5 | 80 | |
| 6 | 52 | |
| 7 | 63 | |
| 8 | 132 | |
| 9 | Oral ciprofloxacin in refractory gram-negative bacillary infections. | 2 |
| 10 | 46 | |
| 11 | 37 | |
| 12 | 44 | |
| 13 | 4 | |
| 14 | 55 |
About A I Hartstein
A I Hartstein is a scholar working on Molecular Medicine, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 14 papers that have together received 722 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (88 citations), Clinical Biochemistry (188 citations) and Molecular Medicine (118 citations). A I Hartstein has collaborated with scholars based in United States. Frequent co-authors include Virginia H. Morthland, Ploenchan Chetchotisakd, Richard Tucker, Pamela Williams, Maury E. Mulligan, L H Hanson, R Y Kwok, Eduardo Arathoon, David A. Stevens and Richard E. Bryant. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.